I agree Verlin - many staff and officers in Dixon are highly invested and therefore highly motivated to turn things around. But I think what a current holder of something like URF wants to know is how the road to recovery for URF compares to the opportunity cost / alternative investments.
It may well be URF is oversold and holding now is actually a great investment, but I don't think you can count on Dixon to tell you whether that is the case or not. If a Dixon product is not a good investment, Dixon cannot tell their clients to sell out as share prices and reputations would take a significant hit (given the high percentages of Dixon client ownership). And as holders themselves, Dixon staff and officers would lose out.
I think the best thing URF holders can do is obtain their own independent advice or do their own due diligence as others have in this thread. Relying on Dixon doing the right thing (in terms of advising holders of their products) would in my view be ill-advised.
- Forums
- ASX - By Stock
- Ann: Full Year Statutory Accounts
I agree Verlin - many staff and officers in Dixon are highly...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add URF (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $239.9M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 34.0¢ | $17.21K | 50.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 164172 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 197872 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 125000 | 0.340 |
3 | 190000 | 0.335 |
2 | 60600 | 0.330 |
2 | 147591 | 0.325 |
1 | 1 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 197872 | 3 |
0.350 | 46938 | 1 |
0.355 | 62525 | 1 |
0.360 | 294868 | 3 |
0.365 | 39000 | 2 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
URF (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online